Bayesian Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bayesian Capital Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$221K	Buy
2024 Q3	–	Sell
2024 Q2	$680K	Buy
2024 Q1	$303K	Buy
2023 Q2	–	Sell
2023 Q1	$306K	Buy
2022 Q2	–	Sell
2022 Q1	$301K	Buy
2020 Q2	–	Sell
2020 Q1	$132K	Buy